Global Liquid Biopsy Market Report 2022: A $2.2 Billion Mark...| MENAFN.COM

Thursday, 23 March 2023 07:17 GMT

Global Liquid Biopsy Market Report 2022: A $2.2 Billion Market In 2021 - India, China, South Korea, Brazil, Turkey, Russia, And South Africa Are Expected To Provide Potential Growth Opportunities

(MENAFN- PR Newswire)

DUBLIN, Feb. 6, 2023 /PRNewswire/ -- The 'global liquid biopsy market - analysis by biomarker type (ctcs, ctdna, evs, others), product (assay kits, instruments and devices, services), by indication by region, by country: market size, insights, competition, covid-19 impact and forecast (2023-2028)' report has been added to's

The Global Liquid Biopsy Market was valued at USD 2.2 Billion in the year 2021 backed by several initiatives to raise cancer awareness launched by governments and global health organizations over the last decade.
The report presents the analysis of the Liquid Biopsy market for the historical period of 2018-2021 and the forecast period of 2023-2028.
Developing economies such as India, China, South Korea, Brazil, Turkey, Russia, and South Africa are expected to provide potential growth opportunities for liquid biopsy market players.
This can be attributed to these countries' higher cancer prevalence, large patient populations, improved healthcare infrastructure, rising disposable income, and growing medical tourism. Apart from the previously mentioned factors, the Asia Pacific region has emerged as an adaptable and business-friendly hub due to less stringent regulations and data requirements.
Assay kits are essential for detecting cancer tumor cells or tumor DNA using liquid biopsy. Liquid biopsy assays are low-cost, minimally invasive procedures that aid in patient monitoring during and after treatment and screening.
Other major factors driving the growth of the liquid biopsy assay kits market include the availability of a wide range of reagents and kits, easy access to a wide range of assays, and the rising prevalence of cancer.
The high adoption of advanced technologies such as NGS, the increasing number of research studies for the discovery and development of novel cancer biomarkers, the presence of many pharmaceutical companies, rising funding and investments from public and private organizations, and the increasing use of biomarkers in patient stratification and drug development processes are driving growth in North America's developed markets.
The report tracks competitive developments, strategies, mergers, and acquisitions, and new Biomarker development.

Competitive Positioning

  • Companies' Product Positioning
  • Market Position Matrix
  • Market Share Analysis of Liquid Biopsy Market
  • Company Profiles

The companies analyzed in the report include

  • Roche Holding AG
  • Abbott Laboratories
  • Illumina Inc.
  • Biocartis
  • Guardant Health
  • Thermo Fisher Scientific
  • Biocept, Inc.
  • Bio-Rad Laboratories
  • MDxHealth

Key Topics Covered:

1. Introduction
1.1 Liquid Biopsy Market Overview
1.2 Scope of Research
2. Executive Summary
2.1 Market Snapshot
2.2 Regional Insights
2.3 Market Ecosystem Factors
3. Research Methodology
3.1 Data Collection Process
3.2 Market Trajectory Estimation
3.3 Market Size Calculation-Top-to-Bottom
4 Market Dynamics
4.1 Drivers
4.2 Restraints
4.3 Opportunities
4.4 Analyst Recommendations
4.5 Trends
4.6 Impact Analysis
5. Value Chain Analysis
5.1 Value Chain Analysis of Liquid Biopsy Market
6 COVID-19 Impact Assessment
6.1 Degree of Impact of COVID-19 on Liquid Biopsy Market
6.2 Region-Wise Quarterly Covid Impact Analysis (2020)
7 Porter's five forces analysis
8 Macro Economic Indicator Outlook
8.1 GDP per capita growth (annual %)
8.2 Global Medical Spending in 2020, By Region, (% of Total)
8.3 Current Healthcare Expenditure
8.4 Pharmaceutical Spending/capita
8.5 Cancer Incidence
9 Global Liquid Biopsy Market
9.1 Impact Analysis of Macro Economic Factors on Liquid Biopsy Market
9.2 Snapshot
9.3 Global Liquid Biopsy Market: Market Value Assessment
9.4 Market Summary
10. Global Liquid Biopsy Market Trend And Forecast Analysis, 2018-2028, By Biomarker Type
10.1 Global Liquid Biopsy Market Trend And Forecast Analysis, Biomarker Type: Snapshot
10.2 Circulating tumor cells (CTCs)
10.3 Circulating tumor DNA (ctDNA)
10.4 Extracellular vesicles
10.5 Other Biomarkers
11. Global Liquid Biopsy Market Trend And Forecast Analysis, 2018-2028, By Indication
11.1 Global Liquid Biopsy Market Trend And Forecast Analysis, By Indication: Snapshot
11.2 Cancer
11.3 Prenatal Screening
11.4 Others
12. Global Liquid Biopsy Market Trend And Forecast Analysis, 2018-2028, By Product
12.1 Global Liquid Biopsy Market Trend And Forecast Analysis, By Product: Snapshot
12.2 Assay Kits
12.3 Instruments and Devices
12.4 Services
13. Global Liquid Biopsy Market Trend And Forecast Analysis, 2018-2028, By Region
13.1 Regional Coverage of the Study

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Media Contact:
Research and Markets
Laura Wood, Senior Manager
[email protected]
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


SOURCE Research and Markets


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.